Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

Detection of Phosphorylated Alpha-synuclein Through Routine Colonoscopy to Diagnose Parkinson's Disease and Related Disorders

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease? Currently, Parkinson's disease is diagnosed by observing symptoms like tremors and movement problems, but by then the disease has already progressed significantly. Earlier detection could help doctors start treatment sooner.

Who May Be Eligible (Plain English)

Who May Qualify: - Adults 40 to 99 years of age - Patients with a confirmed clinical diagnosis of Parkinson's disease by UKPDS Brain Bank Criteria - Patients who have agreed to undergo a routine colonoscopy as part of their surveillance for colon cancer or exclusion of other gastrointestinal diseases Who Should NOT Join This Trial: - Use of anticoagulants (Plavix 75 mg or aspirin up to 325 mg alone is allowed) - History of colon cancer - Recent gastrointestinal illness or surgical procedures - Pregnant or planning to become pregnant before the scheduled colonoscopy - Significant cognitive impairment, as determined by study investigators - Decisionally impaired adults who cannot express understanding that this study is voluntary and for research purposes Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adults 40 to 99 years of age * Patients with a confirmed clinical diagnosis of Parkinson's disease by UKPDS Brain Bank Criteria * Patients who have agreed to undergo a routine colonoscopy as part of their surveillance for colon cancer or exclusion of other gastrointestinal diseases Exclusion Criteria: * Use of anticoagulants (Plavix 75 mg or aspirin up to 325 mg alone is allowed) * History of colon cancer * Recent gastrointestinal illness or surgical procedures * Pregnant or planning to become pregnant before the scheduled colonoscopy * Significant cognitive impairment, as determined by study investigators * Decisionally impaired adults who cannot express understanding that this study is voluntary and for research purposes

Treatments Being Tested

DIAGNOSTIC_TEST

No Intervention: Observational Cohort

No Intervention: Observational Cohort

Locations (1)

Oregon Health & Science University
Portland, Oregon, United States